Heartware International, Inc. (HTWR) - NASDAQ
  • Sep. 2, 2015, 9:05 AM
    • HeartWare International (NASDAQ:HTWR) acquires Israel-based privately-held Valtech Cardio for up to 5.9M shares of HTWR common stock or ~$425M based on a price of $72 per share. Valtech specializes in surgical and transcatheter valve repair and replacement devices for the treatment of mitral valve regurgitation and tricuspid valve regurgitation.
    • Under the terns of the agreement, Valtech shareholders will receive 4.4M HTWR common shares upfront, 800K shares upon CE Mark clearance of Cardioband and 700K shares upon the earlier of first-in-patient implants of either Cardioband tricuspid or CardioValve. The deal also includes warrants to purchase 850K shares of HTWR common stock at $83.73 contingent on the achievement of $75M in net sales of Valtech products and a $375M earn-out payment upon the attainment of $450M in net sales of Valtech offerings. The earn-out can be in either stock or cash at HeartWare's discretion.
    • HTWR is down 13% premarket on increased volume.
    | Sep. 2, 2015, 9:05 AM
  • Jul. 21, 2015, 12:41 PM
    • Heart pump maker Thoratec (THOR +16.1%) jumps on rumors of a bid by St. Jude Medical (STJ +0.4%).
    • Competitor Heartware (HTWR +7.3%) moves up in tandem.
    | Jul. 21, 2015, 12:41 PM
  • Mar. 29, 2012, 7:32 PM

    HeartWare International (HTWR) acquires World Heart (WHRT), a developer of of left ventricular assist heart devices, for $8M in an all stock transaction. WHRT +3.7% AH.

    | Mar. 29, 2012, 7:32 PM | 1 Comment
Company Description
HeartWare International, Inc. is a medical device company which develops and manufactures miniaturized implantable heart pumps or ventricular assist devices to treat patients suffering from advanced heart failure. The company was founded on July 29, 2008 and is headquartered in Framingham, MA.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States